Search

Your search keyword '"Xiaojiang Cui"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Xiaojiang Cui" Remove constraint Author: "Xiaojiang Cui" Topic breast cancer Remove constraint Topic: breast cancer
68 results on '"Xiaojiang Cui"'

Search Results

1. Human breast organoid models for lactation research

2. Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions

3. Breast cancer liver metastasis: Pathogenesis and clinical implications

4. CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions

5. A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth

6. Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth

7. Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment

8. Current Status of Breast Organoid Models

9. Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation

10. A Novel Long Non‐Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis

11. Breast cancer lung metastasis: Molecular biology and therapeutic implications

12. Abstract 2965: Generation of a human breast tissue mimetic organoid model

13. FOXC1: an emerging marker and therapeutic target for cancer

14. Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis

15. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort

16. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance

17. Abstract P6-17-05: A corrole nanobiologic crosses the blood-brain-barrier and recognizes triple negative breast cancer: Implications for targeting brain metastases

18. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway

19. Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging

20. Translational Challenges and Therapeutic Opportunities in BRCA1-Related Breast Cancer

21. Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis

22. c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion

23. Current Status of Anti–Human Epidermal Growth Factor Receptor 2 Therapies: Predicting and Overcoming Herceptin Resistance

24. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

25. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation

26. FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer

27. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers

28. Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study

29. FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

30. Evaluation of MCF10A as a reliable model for normal human mammary epithelial cells

31. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay

32. Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer

33. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer

34. Regulatory Nodes That Integrate and Coordinate Signaling as Potential Targets for Breast Cancer Therapy

35. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status

36. Personalizing breast cancer staging by the inclusion of ER, PR, and HER2

37. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

38. Biology and Treatment of Basal-Like Breast Cancer

39. WE-FG-BRA-11: Theranostic Platinum Nanoparticle for Radiation Sensitization in Breast Cancer Radiotherapy

40. Abstract P5-01-03: Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging

41. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling

42. Prognostic value of basal phenotype in HER2-overexpressing breast cancer

43. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling

44. Stratifying Prognosis of Triple-Negative Breast Cancer Patients Treated With Breast Conserving Therapy and Mastectomy Using Basal Biomarkers

45. Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer.

46. Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.

47. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2

48. Abstract 4487: Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

49. Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer

50. The basal phenotype as a clinically relevant indicator of trastuzumab resistance in HER2+ breast cancer

Catalog

Books, media, physical & digital resources